1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester
| 中文名称 | 1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester |
|---|---|
| 中文同义词 | 化合物T9078;化合物 LY3405105 |
| 英文名称 | 1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester |
| 英文同义词 | 1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester;(3S)-1-[(E)-4-(dimethylamino)but-2-enoyl]pyrrolidin-3-yl] 4-[(3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino]piperidine-1-carboxylate;anticancer,Cyclin dependent kinase,CDK,MCF7,SNU-16,Cyclin-dependent kinase,LY 3405105,LY3405105,HCC1806,inhibit,Inhibitor,LY-3405105,HCT116 |
| CAS号 | 2326428-25-3 |
| 分子式 | C26H39N7O3 |
| 分子量 | 497.63 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 2326428-25-3.mol |
| 结构式 | ![1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester 结构式](CAS/20210111/GIF/2326428-25-3.gif) |
1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester 性质
| 密度 | 1.27±0.1 g/cm3(Predicted) |
|---|---|
| 储存条件 | Store at -20°C |
| 溶解度 | DMSO：99 mg/mL (198.94 mM)；乙醇：99 mg/mL (198.94 mM) |
| 酸度系数(pKa) | 8.26±0.28(Predicted) |
| 形态 | 固体 |
| 颜色 | 白色至米白色 |
| 水溶解性 | Water: Insoluble |
1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester 用途与合成方法
CDK7-IN-4 (compound I) 是一种有效的 CDK7 (细胞周期蛋白依赖激酶 7) 抑制剂。CDK7-IN-4 显示出抗癌活性。CDK7-IN-4 以剂量依赖性的方式抑制结肠、乳腺、肺、卵巢和胃等多种组织学肿瘤细胞系的体外生长。